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ABSTRACT OF THE DISSERTATION 
 
 
Upper Airway Anatomy: Factors to predict OSA severity and changes induced by Mandibular 
Repositioning Appliances 
 
 
 
by 
 
 
 
William Paul Boggess 
 
Master of Science in Oral Biology 
 
University of California, Los Angeles, 2020 
 
Professor Sanjay Mallya, Chair 
 
 
 
Anatomic constriction and collapse of the upper airway are key to development of obstructive 
sleep apnea. The first aim of this study was to identify upper airway anatomic features that 
correlate with AHI severity. The second aim was to evaluate changes to the upper airway caused 
by mandibular repositioning appliances and to identify potential predictors of the therapeutic 
response. Our study did not identify any anatomic correlates of AHI severity, indicating the 
contribution of other factors to OSA development, in addition to anatomic constriction. 
Mandibular repositioning appliances induced a statistically significant increase in the 
velopharyngeal dimensions, suggesting that muscular repositioning of the tongue as well as the 
pharyngeal and palatal muscles may play a role in its therapeutic actions. 
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Introduction 
 
     Obstructive sleep apnea (OSA) is characterized by episodes of partial or 
complete obstruction of the upper airway during sleep, interrupting (apnea) or 
reducing (hypopnea) the flow of air, followed by transient awakening that leads 
to the resolution of the upper airway collapse [1]. The cause of the disease is 
multifactorial with the main causes being a reduction of the expansion forces of 
the pharyngeal dilator muscles and discoordination between the inspiratory 
activity of the muscle and respiratory effort[2]. There is growing evidence of OSA 
playing a role in the pathogenesis of cardiovascular and metabolic diseases 
and a strong association with increased mortality rates [3].  
     An overnight polysomnography study is the most reliable confirmation for an 
OSA diagnosis [4]. A common measurement for the severity of OSA is the 
Apnea-Hypopnea Index (AHI); which is an average that represents the 
combined number of apneas and hypopneas that occur per hour of sleep. OSA 
is divided into three types by the American Academy of Sleep Medicine 
(AASM).   
• Mild OSA: AHI of 5-15 – involuntary sleepiness during activities that require 
little attention, such as watching tv or reading. 
• Moderate OSA: AHI of 15-30 – involuntary sleepiness during activities that 
require some attention, such as meetings or presentations. 
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• Severe OSA: AHI of more than 30 – involuntary sleepiness during activities 
that require more active attention, such as talking or driving. 
      
The prevalence of obstructive sleep apnea had a mean of 22% (range, 9-37%) 
in men and 17% (range, 4-50%) in women in eleven published epidemiological 
studies published between 1993 and 2013[5]. The gold standard for treatment of 
moderate to severe OSA is continuous positive airway pressure (CPAP) but 
treatment can be challenging because of low patient compliance and 
adherence to the treatment [6]. Mandibular repositioning appliances (MRAs) 
are an effective treatment for mild to moderate OSA.  Short term (health 
outcomes at one month) show MRA therapy to be comparable to CPAP [7].  
   
Upper Airway 
     The upper respiratory tract has a complex anatomical arrangement of 
skeletal muscles and soft tissues. The anatomy can be divided into 4 main 
segments. The nasopharynx that is superior to the hard palate, the velopharynx 
between the hard palate and the tip of the uvula, the oropharynx that is 
between the tip of the uvula and the tip of the epiglottis and the hypopharynx 
from the tip of the epiglottis to the vocal cords.  
     The musculature has an internal longitudinal layer and an external circular 
layer. The longitudinal layer consists of the salpingopharyngeus, 
palatopharyngeus and stylopharyngeus muscles and their function is to elevate 
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the pharynx and larynx during speech and swallowing. The circular layer consists 
of the superior, middle and inferior pharyngeal constrictor muscles which 
constrict the pharynx during swallowing. 
     The soft palate is a movable fold that extends the hard palate 
posteroinferiorly to the uvula and forms an incomplete septum between the 
mouth and the pharynx. The lower border is free and the most inferior portion is 
called the uvula. Its function is to close off the nasopharynx in swallowing, while 
suckling and during speech[8]. The relationship between uvula size and sleep-
disordered breathing is lacking in data for objective interpretation. Uvular length 
> 15 mm is considered elongated [9]. OSA patients have significantly longer soft 
palate length and the percentage of the airway taken up by the soft palate is 
greater than non-OSA patients [10]. 
     Minimum pharyngeal airway space in a patient with no apparent symptoms 
of OSA has a 7.6 mm mean and 6.5 mm median (range 5.4 mm, 25% to 9.3 mm, 
75%)[11]. An area of constriction less than 37.4 mm2 was found to predispose a 
subject to OSA [12]. 
 
Cone Beam Computed Tomography (CBCT) 
      Evaluation of OSA using polysomnography is time consuming and 
expensive[13]. Therefore, attempts have been made to search for imaging 
modalities that would directly reflect the status of the upper airway[14]. Dental 
radiography was revolutionized when cone beam computed tomography 
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(CBCT) became readily available in the late 1990’s. Since then interest in it has 
rapidly increased in dental research and clinical practice among general 
dentists and specialists alike [15]. The ability to perform a three-dimensional 
evaluation of the upper airway coupled with the lower radiation dose 
compared to medical CT imaging makes CBCT a potentially attractive tool for 
the assessment of airway anatomy in OSA patients [16]. Despite low soft tissue 
resolution, CBCT shows high contrast between bone, empty spaces and soft 
tissues in general so the airway can be visualized ideally in relation to the hard 
tissue structures of the skull[17]. Reliability of the CBCT imaging has been 
evaluated in comparison to multidetector CT and the measurements of the 
upper airway space using CBCT were fairly accurate[18]. The reliability of upper 
airway analysis with CBCT has great variability between examiners but improves 
with examiner experience. Assessment of the oropharynx is the most reliable 
area of upper airway; however, the velopharynx and hypopharynx has 
generally low reliability between examiners [19]. Adequate training in CBCT 
analysis is needed to provide the highest level of measurement reliability [19]. In 
the supine position, the velopharynx is the most changeable site in the upper 
airway, when compared to the oropharynx and hypopharynx in the upright 
position[20]. 
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Specific Aims 
Specific Aim1: To examine whether anatomic features of the upper airway, as 
determined on CBCT scans correlate with OSA severity, as categorized by the AHI 
score.   
Specific Aim1: To evaluate anatomic changes to the upper airway caused by an 
MRA and the impact of these changes on therapeutic success of the appliance. 
 
Materials and Methods 
 
Patients and recruitment:  
The study population was recruited from OSA patients referred to the UCLA 
Orofacial Pain Clinic for MRA therapy.  
The inclusion and exclusion criteria were as below: 
Inclusion criteria 
• Age: 25 years or older. This age group is selected to represent the broad age 
range of patients that are typically treated with MRA for OSA. 
• Apnea-hypopnea index (AHI, as determined by polysomnography): 5-30, 
representing mild to moderate OSA. 
• Adequate number of teeth in good health to support the dental appliance. 
 
Exclusion criteria 
• Inability to reliably keep appointments for the treatment and follow-up visits. 
• Pregnant patients. 
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Severe dental disease.  
This study was approved by the Institutional Review Board of UCLA. 
Mandibular Repositioning Appliance 
     The mandibular repositioning appliance used in this study was the Adjustable 
Herbst Appliance. The appliance has customized maxillary and mandibular trays 
with telescopic arms. The trays do not come apart and allow 2-3 mm of lateral 
movement. The telescopic arms are adjustable at ¼ mm increments with a 
recommended maximum expansion of 5 mm. The pre-fabrication record of bite 
was recorded in the anterior end to end position.  
 
 
Radiographic Imaging 
     CBCT scans were taken both before treatment and right after MRA delivery 
(n=43). An additional follow-up CBCT scan was taken on 12 subjects. All CBCT 
scans were taken by a NewTom 5G machine in an 18x16 field of view with a 14-
bit gray scale. Scan times were 18 seconds (3.6 seconds emission time), 110 kV, 
and utilized an automatic exposure control that adjusted the milliampere based 
upon the patient’s anatomic density. Data from the CBCT was reconstructed to 
produce 0.3mm slices.  
CBCT volumes and Reference Planes 
 7 
 
DICOM files from CBCT examinations were imported into Invivo6 (Anatomage, 
CA). To standardize anatomic positioning and measurements, the imaged 
volume was re-oriented in the three orthogonal planes as below (Figure 1): 
Sagittal plane: Included anterior nasal spine (ANS), posterior nasal spine (PNS) 
and nasion (N) 
Horizontal plane: Plane perpendicular to the midsagittal plane and including 
the ANS and PNS 
 
Figure 1: Orthogonal Planes 
Upper Airway Assessment 
     The built-in airway module in InVivo was used to segment the upper airway 
from the palatal plane to the deepest point in the laryngeal vallecula (Figure 2). 
The software program automatically generates linear (antero-posterior) and 
area measurements at 0.5mm intervals along the airway length. Data was 
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exported in tabular format and imported into Graphpad Prism for further 
analyses. Summary statistic incudes the maximum, minimum and average Ap 
dimension and area measurement.  
 
 
Figure 2: Airway Assessment 
     The area from the horizontal palatal plane to the tip of the uvula in the 
midsagittal plane was defined as the velopharynx. The deepest point of the 
laryngeal vallecula to the tip of the epiglottis was used as the hypopharynx. The 
tip of the epiglottis to the tip of the uvula was used as the oropharynx.  
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  Each subject had their unique velopharynx, oropharynx and hypopharynx 
areas determined, the minimum cross-sectional area and minimum A-P length 
were obtained from the data chart for each level in the upper airway.  
 
 
Data Analysis 
     Data sets obtained from the CBCT radiographs were transferred to Microsoft 
Excel. A single linear regression model for log-transformed AHI scores was utilized 
for the predictors at pre-treatment. For the posttreatment changes, pre and post 
comparisons in pharyngeal measurements were made. The lack of a model linking 
pharyngeal measurements to OSA severity limits the clinical relevance of any 
significant differences found. However, if a future model is found, these results 
could form the basis of a novel clinical intervention for OSA sufferers seeking 
treatment. 
     First, t-tests were conducted on the differences in measurement before and 
after the intervention with the mandibular repositioning device.  For the three 
regions (velopharynx, oropharynx and hypopharynx), m in imum cros s -
sect iona l  area and minimum A-P length measurements were obtained. The null 
hypotheses were that the difference between pre and post measurements were 
zero while the alternative hypotheses were that there was a difference.  Both 
absolute differences and percent differences were calculated and tested, 
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resulting in a total of 12 t-tests.  Since there is presumably a degree of dependence 
between measurements of differences and percent differences, the Bonferroni 
correction applied was a reduction in alpha-level by a factor of six, not 12. If a 
p-value falls below 0.00833, it will be rejected.  Criticism of the Bonferroni 
method commonly centers on its conservativeness with high numbers of tests[21]; 
however, for even any given test here, the rejection threshold is almost an order of 
magnitude stricter than the original threshold, so even with this modification, the 
standard is reasonably strict.  For re-interpretation with a Bonferroni correction 
of 12, the rejected tests would be velopharynx area difference and length 
percent difference (alpha-level is 0.05/12, or 0.00416). Due to the dependent 
nature of the percent difference tests (for example, in these results, all significant 
differences also had significant percent differences and vice-versa), the 
Bonferroni correction of six is recommended at this time. 
     The single linear regression model for log-transformed AHI scores and the t-tests 
with the Bonferroni correction applied were completed by senior Master’s 
students Zanyu Shi and Sean Campeau in the UCLA Department of Biostatistics. 
GraphPad Prism version 8.2.0 (435) was used for the anatomical analysis and 
graphing. Brown-Forsythe ANOVA tests were used for analysis between groups. 
Dunnett's T3 multiple comparisons tests were used for analysis of statistically 
significant results. 
 
Predictive Factors 
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 Prognostic factors analyzed in the pre-treatment upper airway were: 
• Amount of A-P length constriction vs OSA severity 
• Amount of cross-sectional area constriction vs OSA severity 
• Level of A-P constriction vs OSA severity 
• Level of cross-sectional area constriction vs OSA severity 
• Validity of A-P Score 
• Validity of Cross-sectional Area Score 
Anatomical analysis in the pre-treatment airway: 
• Differences between A-P constriction length in OSA severity groups 
• Differences between cross-sectional constriction area in OSA severity 
groups 
• Differences between level of constriction in OSA severity groups 
• Differences between amount of constriction at each level in OSA severity 
groups 
Prognostic factors analyzed in the post-delivery upper airway were: 
• Does the MRA change the upper airway? 
• What changes are observed? (positive, negative) 
• Are significant changes correlated with specific upper airway levels?  
Anatomical analysis of the post-delivery upper airway: 
• Change in A-P constriction vs OSA severity (mm, %) 
• Change in minimum cross-sectional area vs OSA severity (mm2, %) 
• Change in A-P constriction vs level (mm, %) 
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• Change in minimum cross-sectional area vs level (mm2, %) 
MRA analysis 
• MRA advancement across all subjects (%) 
• MRA advancement vs OSA severity (%) 
 
     Subjects recruited into the study received standard diagnostic and 
therapeutic clinical practices, non-standard or investigational practices were 
not used.  The ages ranged from 29-88 years with a mean age of 69 years. The 
pre-treatment AHI numbers ranged from 1 to 47 with equal numbers of male 
and female subjects. Polysomnogram results for the subjects: 
• AHI less than 5 or normal*:        n= 5 
• AHI between 5 but less than 15 or mild OSA:    n=19 
• AHI between 15 but less than 30 or moderate OSA:   n=5  
• AHI greater than 30 or severe OSA:      n=3  
*Although these patients have an AHI score that is considered normal, 
each patient had OSA symptoms, and either a high Respiratory Distress 
Index (RDI) or high Respiratory Event index (REI). 
     The number of subjects recruited into the study and also received a pre-
treatment CBCT radiograph was 62. The number of subjects with a pre-
treatment AHI, pre-treatment CBCT radiograph and a CBCT radiograph at 
delivery of the MRA was 32. This group of 32 patients were the subjects 
evaluated in the study. 
 13 
 
 
RESULTS 
 
 
Summary of factors: 
 
Variable Coefficient Number of cases Estimate Std. Error t value Pr(>|t|) 
Velopharynx 
(Ref: >6mm n=6) 
Intercept  - 1.7233 0.3338 5.1629 <0.0001 
Less than 6mm 26 0.5775 0.3703 1.5595 0.1294 
Oropharynx 
(Ref: >6mm n=21) 
Intercept - 2.1494 0.1850 11.6171 <0.0001 
Less than 6mm 11 0.1254 0.3156 0.3975 0.6938 
Hypopharynx 
(Ref: >6mm n=21) 
intercept - 2.1688 0.1854 11.7004 <0.0001 
Less than 6mm 11 0.0690 0.3162 0.2184 0.8286 
AP Score 
(Ref: 0-3 n=16) 
Intercept - 2.0594 0.2097 9.8195 <0.0001 
6-9 16 0.2662 0.2966 0.8975 0.3766 
Area Score 
(Ref: 0-3 n=17) 
Intercept - 2.1433 0.2058 10.4163 <0.0001 
5-15 15 0.1051 0.3005 0.3496 0.7291 
Velopharynx 
(Ref: 50-90 mm2 n=15) 
Intercept - 2.4740 0.2045 12.0989 <0.0001 
Greater than 
90mm2 7 0.3025 0.3233 0.9355 0.3573 
Less than 50 
mm2 10 -0.5521 0.3903 -1.4147 0.1678 
Oropharynx 
(Ref: >90 mm2 n=24) 
Intercept - 2.2096 0.1764 12.5283 <0.0001 
Between 50-
90mm2 5 0.0340 0.6310 0.0539 0.9573 
Less than 50 
mm2 3 0.0896 0.5291 0.1694 0.8667 
Hypopharynx 
(Ref: >90 mm2 n=22) 
Intercept - 2.1563 0.1795 12.0119 <0.0001 
Between 50-
90mm2 3 -0.6998 0.5810 -1.2045 0.2381 
Less than 50 
mm2 7 -0.3259 0.3654 -0.8920 0.3797 
 Level of Constriction A-P 
(ref: Hypo n=8) 
Intercept - 2.0181 0.2838 7.1109 <0.0001 
o 1 1.8321 0.8514 2.1518 0.0399 
v 23 0.1631 0.3295 0.4949 0.6244 
Level of Constriction Area 
(ref: Hypo n=9) 
Intercept - 1.9712 0.2793 7.0568 <0.0001 
v 23 0.3080 0.3295 0.9347 0.3574 
 
All factors to predict OSA severity that were analyzed in the pre-treatment 
airway showed no correlation to the AHI Score obtained after polysomnography 
(p> 0.05).  
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Summary of Changes: 
 
Velopharynx Minimum Median Mean Maximum P Value Significant 
Change (mm) -2.7828 1.1090 1.0709 5.3842 0.00583 Yes 
Change (%) -50.19 21.93 39.60 189.34 0.00144 Yes 
Change(mm2) -45.394 -2.507 26.593 176.948 0.00198 Yes 
Change (%) -31.99 37.17 56.43 553.23 0.00632 Yes 
 
Oropharynx Minimum Median Mean Maximum P Value Significant 
Change (mm) -5.3667 -0.2793 0.2028 6.3254 0.7260 No 
Change (%) -48.34 -3.75 13.30 128.44 0.1280 No 
Change(mm2) -133.45 20.578 24.830 179.074 0.0718 No 
Change (%) -56.62 16.15 30.88 176.64 0.0052 Yes 
 
Hypopharynx Minimum Median Mean Maximum P Value Significant 
Change (mm) -7.7278 0.3527 0.2892 7.5667 0.6200 No 
Change (%) -62.78 9.41 16.23 188.25 0.0981 No 
Change(mm2) -111.76 16.25 22.33 207.28 0.1200 No 
Change (%) -46.86 30.58 49.40 575.77 0.0201 No 
 
All changes in area and A-P in the velopharynx and the percentage area 
change in the oropharynx were significantly positive (p> 0.00833).  
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Distribution of AHI score in the pretreatment airway.  
 
 
 
u Normal    n=5 
u Mild    n=19 
u Moderate   n=5 
u Severe   n=3 
 
The range of AHI Scores varied from the least severe at 1 to the most severe at 
47. 
 
All patients have OSA symptoms; yet, five patients had an AHI below 5 after the 
polysomnogram. Three of these patients were diagnosed with Upper Airway 
Resistance Syndrome while the remaining two patients had snoring, insomnia 
and daytime tiredness. 
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Due the distribution of AHI scores, a log-transformation was conducted on AHI 
scores to make its distribution more approximated to a normal distribution, which 
is a prerequisite for t-test and other parametric analysis. 
Log Transformation of AHI scores 
 
 
 
Model for predictors  
 
Single linear regression models for log-transformed AHI scores and the predictors 
on pre-treatment airways were utilized. The Single linear regression models test 
was used for correlation between single variables and the outcome AHI scores 
in the pre-treatment airway. 
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Is there a significant difference of the AP length among OSA severity groups at 
various segments of the upper airway? 
 
   
 
 
Brown-
Forsythe 
ANOVA 
F(DFn,DFD) 
   
P value Significant 
Difference  
Velopharynx 0.2087(3,12.9) 0.8885 No 
Oropharynx 0.1503 (3,16.6) 0.9280 No 
Hypopharynx 2.700(3,13.2)  0.0881 No 
 
The null hypothesis is that the average minimum A-P length at various levels of 
the upper airway is the same (Ho: L normal =L mild =L moderate =L severe).  
The analysis of these data sets, failed to reject the null hypothesis.  
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Is there a significant difference of the area of maximum constriction among OSA 
severity groups at various levels of the upper airway? 
 
 
 
 
 
Brown-
Forsythe 
ANOVA 
F(DFn,DFD) 
  (3, 28) 
P value Significant 
Difference  
Velopharynx 0.3023 (3, 18.4) 0.5352 No 
Oropharynx 0.4739 (3, 14.4) 0.3481 No 
Hypopharynx 0.1466 (3, 13.1) 0.9110 No 
 
The null hypothesis is that the average area of maximum constriction at various 
levels of the upper airway is the same (Ho: L normal =L mild =L moderate =L 
severe). The analysis of these data sets, failed to reject the null hypothesis.  
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At what level in the upper airway does the minimum A-P length occur? 
 
 
 
The minimum AP dimension occurred in the velopharynx 72% of the time. One 
patient has the minimum AP length in the oropharynx. In cases with the initial 
constriction in the velopharynx, this is the only constriction point below 6 mm in 
57% if the patients. 
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Is there a significant difference of the AHI score among patients with initial A-P 
constriction at various levels of the upper airway? 
 
Variable Coefficient Number of 
cases 
Estimate Std.Error t Value Pr(>|t|) 
Level of 
Constriction 
(ref: Hypo n=8) 
Intercept - <2.0181 0.2838 7.1109 <0.0001 
Oropharynx 1 <1.8321 0.8514 2.1518 0.0399 
Velopharynx 23 <0.1631 0.3295 0.4949 0.6244 
 
 
 
The null hypothesis is that there is no difference in the effects of level of initial 
constriction to the AHI score (Ho: L velopharynx =L oropharynx =L hypopharynx). 
The analysis of these data sets, failed to reject the null hypothesis. The analysis of 
these data sets, failed to reject the null hypothesis in the velopharynx and 
hypopharynx. Even though the p-value in the oropharynx is less than 0.05; 
because only one patient is initially constricted at this level, evidence to reject 
the null hypothesis is weak.  
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Is there a significant difference of the AP length among various levels of the 
upper airway in different OSA severity groups? 
 
 
 
Brown-
Forsythe 
ANOVA 
F(DFn,DFD) 
   
P value Significant 
Difference  
Normal  2.302 (2, 12) 0.1428 No 
Mild  5.318 (2, 45.3) 0.0084 Yes 
Moderate  1.234 ( 2, 7.6) 0.3433 No 
Severe 1.737 (2, 4.1) 0.2838 No 
 
The null hypothesis is that the average minimum A-P length at various levels of 
the upper airway is the same (Ho: L velopharynx =L oropharynx =L 
hypopharynx). The analysis of these data sets, failed to reject the null hypothesis 
in the normal, moderate and severe OSA groups. There is a statistically 
significant difference in the constriction area for patients with mild OSA.  
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Among what levels in the upper airway is the difference noted for patients with 
mild OSA? 
 
Dunnett's T3 multiple 
comparisons test (Mild) 
Mean Diff. 95.00% CI of diff. Significant? Summary Adjusted 
P Value 
 
Velopharynx vs. Oropharynx -3.848 -7.407 to -0.2881 Yes * 0.0143 A-B 
Velopharynx vs. 
Hypopharynx 
-3.090 -6.077 to -0.1039 Yes * 0.0196 A-C 
Oropharynx vs. Hypopharynx 0.7572 -3.167 to 4.682 No ns 0.9303 B-C 
 
A statistically significant difference is noted between the constriction area of the 
velopharynx vs the oropharynx and the velopharynx vs the hypopharynx in the 
mild OSA group.  
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At what level in the upper airway does the minimum cross-sectional area occur? 
 
 
The minimum cross-sectional area occurred 72 % in the velopharynx. In cases 
with the initial constriction in the velopharynx, this is the only constriction point 
below 90 mm2 in 74% if the patients. There were no patients that has the area of 
maximum constriction the oropharynx. 
 
 
Is there a significant difference of the AHI score among patients with initial 
minimum cross-sectional area at various levels of the upper airway? 
 
Variable Coefficient Number of 
cases 
Estimate Std.Error t Value Pr(>|t|) 
Level of 
Constriction 
(ref: Hypo 
n=9) 
Intercept - 1.9712 0.2793 7.0568 <0.0001 
v 23 0.3080 0.3295 0.9347 0.3574 
 
The null hypothesis is that there is no difference in the effects of level of initial 
constriction to the AHI score (Ho: L velopharynx =L oropharynx =L hypopharynx). 
The analysis of these data sets, failed to reject the null hypothesis. 
 
 
 
 24 
 
Is there a significant difference of the cross-sectional area among various levels 
of the upper airway in different OSA severity groups? 
 
 
 
Brown-
Forsythe 
ANOVA 
F(DFn,DFD) 
   
P value Significant 
Difference  
Normal  6.854 (2,6.5) 0.0248 Yes 
Mild  5.066 (2,39) 0.0111 Yes 
Moderate  1.586 (2,6.5) 0.2748 No 
Severe 2.245 (2, 4.4) 0.2120 No 
 
The null hypothesis is that the average minimum cross-sectional area at various 
levels of the upper airway is the same (Ho: L velopharynx =L oropharynx =L 
hypopharynx). The analysis of these data sets, failed to reject the null hypothesis 
in the moderate and severe OSA groups. There is a statistically significant 
difference in the constriction area for patients with normal and mild OSA.  
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Between what levels in the upper airway is the difference noted? 
 
Dunnett's T3 multiple 
comparisons test (Normal) 
Mean Diff. 95.00% CI of 
diff. 
Significant? Summary Adjusted P 
Value 
 
Velopharynx vs. Oropharynx -105.3 -164.0 to -46.52 Yes *** 0.0008 A-B 
Velopharynx vs. Hypopharynx -66.59 -200.9 to 67.73 No ns 0.2373 A-C 
Oropharynx vs. Hypopharynx 38.66 -97.23 to 174.6 No ns 0.6070 B-C 
 
 
Dunnett's T3 multiple 
comparisons test (Mild) 
Mean Diff. 95.00% CI of 
diff. 
Significant? Summary Adjusted P 
Value 
 
Velopharynx vs. Oropharynx -95.30 -184.0 to -6.624 Yes * 0.0151 A-B 
Velopharynx vs. Hypopharynx -54.33 -119.6 to 10.98 No ns 0.0744 A-C 
Oropharynx vs. Hypopharynx 40.96 -56.74 to 138.7 No ns 0.5674 B-C 
 
A statistically significant difference is noted between the constriction area of the 
velopharynx vs the oropharynx in both the normal and mild OSA groups.  
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Is there a significant difference between of A-P length between the airways with 
constriction less than 6 mm and greater than 6 mm? 
 
 
 
There is a statistically significant difference between the mean lengths in airways 
that have a constriction less than 6 mm and those that have the minimum 
constriction greater than 6 mm (p=<0.0001).  
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Does the amount of initial AP constriction correlate with OSA severity? 
 
Variable Coefficient Number of 
cases 
Estimate Std.Error t Value Pr(>|t|) 
Velopharynx 
(Ref: >6mm n=6) 
Intercept - 1.7233 0.3338 5.1629 <0.0001 
<6 mm 26 0.5775 0.3703 1.5595 0.1294 
Oropharynx 
(Ref: >6mm n=21) 
Intercept - 2.1494 0.1850 11.6171 <0.0001 
<6 mm 11 0.1254 0.3156 0.3975 0.6938 
Hypopharynx 
(Ref: >6mm n=21) 
Intercept - 2.1688 0.1854 11.7004 <0.0001 
<6 mm 11 0.069 0.3162 0.2184 0.8286 
 
The null hypothesis is that there is no difference in the effects among the amount 
of initial constriction groups and the AHI score (Ho: L less than 6 mm =L greater 
than 6 mm). The analysis of these data sets, failed to reject the null hypothesis.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 AP(mm) Normal Mild Moderate Severe 
Velopharynx >6     n=6 1 4 1 0 
<6     n=26 4 15 4 3 
Oropharynx >6     n=21 4 12 3 2 
<6     n=11 1 7 2 1 
Hypopharynx >6     n=21 3 13 3 2 
<6     n=11 2 6 2 1 
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Is there a significant difference of the area of the airways among various airway 
parameters at various levels of the upper airway?  
 
There is a statistically significant difference among the mean area in airways at 
various cutoff levels (p=<0.0001.  
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Does the amount of the initial area of constriction correlate with OSA severity? 
 
Variable Coefficient Number of 
cases 
Estimate Std.Error t Value Pr(>|t|) 
Velopharynx 
(Ref: 50-90 mm2 
n=15) 
Intercept - <2.4740 0.2045 12.0989 <0.0001 
>90 mm2 7 0.3025 0.3233 0.9355 0.3573 
<50 mm2 10 -0.5521 0.3903 -1.4147 0.1678 
Oropharynx 
(Ref: >90 mm2 
n=24) 
Intercept - <2.2096 0.1764 12.5283 <0.0001 
50-90 mm2 5 0.0340 0.6310 0.0539 0.9573 
<50 mm2 3 0.0896 0.5291 0.1694 0.8667 
Hypopharynx 
(Ref: >90 mm2 
n=22) 
Intercept - <2.1563 0.1795 12.0119 <0.0001 
50-90 mm2 3 -0.6998 0.5810 -1.2045 0.2381 
<50 mm2 7 -0.3259 0.3654 -0.8920 0.3797 
 
The null hypothesis is that there is no difference in the effects among the amount 
of initial constriction groups and the AHI score (Ho: L less than 50 mm2 =L 50 mm2 
to 90 mm2 =L greater than 90 mm2). The analysis of these data sets, failed to 
reject the null hypothesis.  
 
 
 Area (mm2) Normal Mild Moderate Severe 
Velopharynx <50        n=10 1 8 0 1 
50-90     n=15 3 5 5 2 
>90        n=7 1 6 0 0 
Oropharynx <50         n=3 0 3 0 0 
50-90      n=5 0 3 2 0 
>90          n=24 5 13 3 3 
Hypopharynx <50          n=7 0 4 2 1 
50-90       n=3 1 2 0 0 
>90           n=22 4 13 3 2 
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Is the AP Score a useful tool for upper airway analysis?  
 
Velopharynx Oropharynx Hypopharynx 
    
AP Score 0 3 6 9 
Ave Airway (mm) 10.6 7.8 5.6 3.7 
 
The AP Score is a value to indicate the severity of the AP constriction in the 
upper airway. Three points are given to each section of the upper airway 
(velopharynx, oropharynx and hypopharynx) that measures 6 mm or less.  The 
higher the score, the greater the number of areas in the upper airway that have 
an AP constriction less than 6 mm and the average length of the airway is 
smaller; however, this index does not indicate at what level or levels the 
constriction occurs.  
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Is the AP Score a useful tool for predicting OSA severity? 
 
Variable Coefficient Number of 
cases 
Estimate Std.Error t Value Pr(>|t|) 
AP Score 
(Ref: 0-3 n=16) 
Intercept - <2.0594 0.2097 9.8195 <0.0001 
6-9 16 <0.2662 0.2966 0.8975 0.3766 
 
 
The null hypothesis is that the A-P Score has no correlation with the AHI score 
(Ho: L 0-3 =L 6-9). The analysis of these data sets, failed to reject the null 
hypothesis.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AP Score Normal Mild Moderate Severe 
9       n=6 0 5 1 0 
 6       n=10 3 3 2 2 
 3       n=10 1 7 1 1 
0       n=6 1 4 1 0 
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Is the Area Score a useful tool for upper airway analysis?  
 
Velopharynx Oropharynx Hypopharynx 
 
Area Score 0 to 3 5 to 15 
Average (mm2) 163.3 73.9 
 
The Area Score is a value to indicate the severity of the area constriction in the 
upper airway. Points are given to each section of the upper airway 
(velopharynx, oropharynx and hypopharynx). Zero points for the constriction 
area above 90 mm2, three points for 50-90 mm2 and five points for constriction 
areas below 50 mm2. There is a large difference between the average area 
between Area Score groups. 
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Is the Area Score a useful tool for predicting OSA severity? 
 
Variable Coefficient Number of 
cases 
Estimate Std.Error t Value Pr(>|t|) 
Area Score 
(Ref: 0-3 n=17) 
Intercept - <2.1433 0.2058 10.4163 <0.0001 
5-15 15 <0.1051 0.3005 0.3496 0.7291 
 
 
The null hypothesis is that the Area Score has no correlation with the AHI score 
(Ho: L 0-3 =L 5-15). The analysis of these data sets, failed to reject the null 
hypothesis.  
 
 
  
Area Score Normal Mild Moderate Severe 
0 to 3       n=17 4 9 2 2 
5 to 15     n=15 1 10 3 1 
 34 
 
MRA Post-Delivery Analysis 
 
What was the percentage of mandibular advancement? 
 
 
 
% Advancement Total Normal Mild Moderate Severe 
Number 32 5 19 5 3 
Mean 38.65 41.00 36.28 41.20 40.67 
Std. Dev 12.25 10.34 14.52 6.54 3.06 
Std. Error 2.20 4.63 3.43 2.92 1.76 
 
Advancement numbers were obtained clinically and the numbers used are 1) 
the amount in mm from maximum intercuspation to an anterior edge position 
and 2) the amount in mm from maximum intercuspation to maximum protrusion. 
The mean advance percentage was 38.65% across all the patients. 
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Is there a statistically significant difference between the amount of mandibular 
advancement between severities? 
 
Dunnett's T3 multiple 
comparisons test 
Mean Diff. 95.00% CI of 
diff. 
Significant? Summary Adjusted P 
Value 
 
Normal vs. Mild  4.722 -16.73 to 26.18 No ns 0.9476 A-B 
Normal vs. Moderate -0.2000 -22.30 to 21.90 No ns >0.9999 A-C 
Normal vs. Severe  0.3333 -22.85 to 23.51 No ns >0.9999 A-D 
Mild vs. Moderate -4.922 -19.82 to 9.975 No ns 0.8451 B-C 
Mild vs. Severe  -4.389 -17.02 to 8.244 No ns 0.8209 B-D 
Moderate vs. Severe  0.5333 -14.12 to 15.18 No ns >0.9999 C-D 
 
There was no statistically significant difference between the amount of 
advancement and severity of OSA.  
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What change is observed in the AP length at various levels of the upper airway 
after MRA delivery? 
 
 
 
Change (mm) Minimum Maximum Range Mean Std. Dev Std Error 
Velopharynx -2.783 5.384 8.167 1.071 2.046 0.3616 
Oropharynx -5.367 6.325 11.69 0.2028 3.242 0.5731 
Hypopharynx -7.728 7.567 15.29 0.2892 3.269 0.5779 
 
 
Change (%) Minimum Maximum Range Mean Std. Dev Std Error 
Velopharynx -50.00 189.0 239.0 39.53 64.05 11.32 
Oropharynx -48.00 128.0 176.0 13.28 48.02 8.488 
Hypopharynx -63.00 188.0 251.0 16.34 53.88 9.524 
 
A large range of change is noted within each level of the upper airway even 
with mandibular advancement showing no statistical significance between 
patients.   
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What change is observed in the AP length among OSA severity groups after MRA 
delivery? 
 
 
 
 
Change (mm) Minimum Maximum Range Mean Std. Dev Std Error 
Normal -1.210 1.576 2.786 0.1594 1.084 0.4849 
Mild -3.046 5.089 8.135 0.8228 1.726 0.3959 
Moderate -0.7426 2.022 2.765 0.6036 1.195 0.5345 
Severe -2.481 4.520 7.001 2.020 3.906 2.255 
 
Change (%) Minimum Maximum Range Mean Std. Dev Std Error 
Normal -16.00 16.00 32.00 1.000 12.39 5.541 
Mild -24.00 71.00 95.00 13.11 20.27 4.650 
Moderate -7.000 24.00 31.00 7.200 13.18 5.894 
Severe -24.00 59.00 83.00 30.33 47.08 27.18 
 
A large range of change is noted within each level of the upper airway even 
with mandibular advancement showing no statistical significance between 
patients.   
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What change is observed in the area at various levels of the upper airway after 
MRA delivery? 
 
 
 
Change (mm2) Minimum Maximum Range Mean Std. Dev Std Error 
Velopharynx -45.39 176.9 222.3 26.59 44.52 7.869 
Oropharynx -133.5 179.1 312.5 24.83 75.35 13.32 
Hypopharynx -111.8 207.3 319.0 22.33 79.07 13.98 
 
Change (%) Minimum Maximum Range Mean Std. Dev Std Error 
Velopharynx -32.00 553.0 585.0 56.44 109.0 19.26 
Oropharynx -57.00 177.0 234.0 30.94 58.18 10.28 
Hypopharynx -47.00 576.0 623.0 49.41 114.1 20.17 
 
A large range of change is noted within each level of the upper airway even 
with mandibular advancement showing no statistical significance between 
patients.   
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What change is observed in the area among OSA severity groups after MRA 
delivery? 
 
 
Change 
(mm2) 
Minimum Maximum Range Mean Std. Dev Std Error 
Normal -52.96 54.02 107.0 14.68 43.48 19.44 
Mild -96.48 158.1 254.6 36.26 59.37 13.62 
Moderate -41.21 136.1 177.3 44.87 69.61 31.13 
Severe -104.8 146.5 251.3 34.85 127.9 73.87 
 
Change (%) Minimum Maximum Range Mean Std. Dev Std Error 
Normal -29.00 29.00 58.00 8.400 23.30 10.42 
Mild -33.00 146.0 179.0 32.16 40.23 9.229 
Moderate -15.00 128.0 143.0 39.60 55.70 24.91 
Severe -48.00 103.0 151.0 39.33 78.23 45.17 
 
A large range of change is noted within each level of the upper airway even 
with mandibular advancement showing no statistical significance between 
patients.   
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Is the minimum A-P constriction change in the velopharynx statistically 
significant?      
 
Velopharynx 
A-P length Minimum Median Mean Maximum P Value Significant 
Change (mm) -2.7828 1.1090 1.0709 5.3842 0.00583 Yes 
Change (%) -50.19 21.93 39.60 189.34 0.00144 Yes 
 
The null hypothesis is that the difference between the pretreatment and post-
delivery airway is zero. The analysis of these data sets rejected the null 
hypothesis. The alternate hypothesis is that the MRA causes change in the 
airway after delivery. The analysis of these data sets with two-sided t-tests 
(p=0.05) and the Bonferroni correction applied (p=0.00833 significance value) 
supports the alternate hypothesis and the change was an increase.   
 
The velopharynx had an overall mean positive change of 1.07 mm or 39.60%. 
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Is the minimum cross-sectional area change in the velopharynx statistically 
significant?      
 
 
Velopharynx 
Area Minimum Median Mean Maximum P Value Significant 
Change(mm2) -45.394 -2.507 26.593 176.948 0.00198 Yes 
Change (%) -31.99 37.17 56.43 553.23 0.00632 Yes 
 
The null hypothesis is that the difference between the pretreatment and post-
delivery airway is zero. The analysis of these data sets rejected the null 
hypothesis. The alternate hypothesis is that the MRA causes change in the 
airway after delivery. The analysis of these data sets with two-sided t-tests 
(p=0.05) and the Bonferroni correction applied (p=0.00833 significance value) 
supports the alternate hypothesis and the change was an increase.   
 
The velopharynx had an overall mean positive change of 26.59 mm2 or 56.43%. 
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Is the minimum A-P constriction change in the oropharynx statistically 
significant?      
 
 
Oropharynx 
A-P length Minimum Median Mean Maximum P Value Significant 
Change (mm) -5.3667 -0.2793 0.2028 6.3254 0.7260 No 
Change (%) -48.34 -3.75 13.30 128.44 0.1280 No 
 
The null hypothesis is that the difference between the pretreatment and post-
delivery airway is zero. The analysis of these data sets failed to reject the null 
hypothesis. 
 
The oropharynx had an overall mean positive change of 0.2028 mm or 13.3%.  
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Is the minimum cross-sectional area change in the oropharynx statistically 
significant?      
 
Oropharynx 
Area Minimum Median Mean Maximum P Value Significant 
Change(mm2) -133.45 20.578 24.830 179.074 0.0718 No 
Change (%) -56.62 16.15 30.88 176.64 0.0052 Yes 
 
The null hypothesis is that the difference between the pretreatment and post-
delivery airway is zero. The analysis of the area data sets failed to reject the null 
hypothesis. The analysis of the percentage change data sets rejected the null 
hypothesis. The alternate hypothesis is that the MRA causes change in the 
airway after delivery. The analysis of the percentage change data sets with two-
sided t-tests (p=0.05) and the Bonferroni correction applied (p=0.00833 
significance value) supports the alternate hypothesis and the change was an 
increase.   
The oropharynx had an overall mean positive change of 24.83 mm2 or 30.88%. 
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Is the minimum A-P constriction change in the oropharynx statistically 
significant?      
 
 
Hypopharynx 
A-P length Minimum Median Mean Maximum P Value Significant 
Change (mm) -7.7278 0.3527 0.2892 7.5667 0.6200 No 
Change (%) -62.78 9.41 16.23 188.25 0.0981 No 
 
The null hypothesis is that the difference between the pretreatment and post-
delivery airway is zero. The analysis of these data sets failed to reject the null 
hypothesis. 
 
The hypopharynx had an overall mean positive change of 0.2892 mm or 16.23%. 
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Is the minimum cross-sectional area change in the hypopharynx statistically 
significant?      
 
 
Hypopharynx 
Area Minimum Median Mean Maximum P Value Significant 
Change(mm2) -111.76 16.25 22.33 207.28 0.1200 No 
Change (%) -46.86 30.58 49.40 575.77 0.0201 No 
 
The null hypothesis is that the difference between the pretreatment and post-
delivery airway is zero. The analysis of these data sets failed to reject the null 
hypothesis. 
 
The Hypopharynx had an overall mean positive change of 22.33 mm2 or 49.4%. 
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Discussion 
     Several upper airway and anatomical variables surrounding the upper airway 
have been used as possible predictors for OSA severity or variables for treatment 
success. The most common variables are related to the constricted site, 
including the AP dimension and minimum cross-sectional area, and in additional 
attributes of the entire oropharyngeal airway including average area, total 
volume and total length were noted among others[22]. In addition to the airway 
anatomy per se, craniofacial anatomic characteristics have been correlated 
with risk of OSA occurrence. In a 2016 meta-analysis of 25 studies, Neelapu 
found a strong correlation between total anterior facial height and reduced 
pharyngeal airway area and inferior position of the hyoid in OSA patients [4]. This 
meta-analysis focused on lateral cephalometric radiographs but suggested 
well-controlled clinical trials using 3-dimentional imaging are required to 
elucidate the precise relationship between craniofacial disharmony and OSA[4]. 
In this study, analysis of the average area showed no strong evidence to prove 
effects or correlation with the AHI score or OSA severity, suggesting that such 
summary statistics are not of practical value to recognizing OSA risk or severity.  
     Momany found that the narrowest cross-sectional area had a significant 
negative correlation with AHI. In this study, patients with AHI scores greater than 
5 were compared to patients with Berlin questionnaire scores showing low or no 
risk of OSA [12]. In our study, the narrowest cross-sectional area showed no 
significant correlation with the AHI score; however, all of the subjects included in 
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our study had OSA symptoms and/or AHI scores greater than 5. In future studies, 
the addition of a control group with low or no risk of OSA would be beneficial to 
recognize the specificity of airway anatomic features for OSA recognition and 
management.   
     Nevertheless, the presence of a narrow airway is a known risk factor for OSA. 
A previous study correlated the narrowest cross-sectional area with likelihood of 
OSA and found that the risk was highest when the  upper airway area was less 
than 52 mm2, intermediate with an upper airway area between 52 mm2 and 110 
mm2, and unlikely with an upper airway area larger than 110 mm2 [23]. The 
mean AHI score was 41.8 with a SD of 17.7. Although this study was done on a 
group of patients with significantly higher AHI scores, the approximate 
probability limits were used in our study. Since our study only had 3 subjects with 
severe AHI, strong evidence supporting Lowe’s probability numbers were weak 
and we found no correlation with AHI scores in our current study.  
     The currently used primary parameter to indicate success with MRA therapy is 
a reduction in the initial AHI score by 50%. Due to limitation in the number of 
patients with post-delivery AHI scores, the indicator for success was changed to 
a significant probability to observe an increase in the area of constriction after 
MRA delivery. The first question that needs to be answered is whether 
mandibular advancement with and MRA changes the upper airway. There were 
observed changes at all levels of the upper airway after MRA delivery. The AP 
and cross-sectional area constrictions were assessed in the velopharynx, 
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oropharynx and hypopharynx. Both positive and negative changes were 
detected at each level of constriction but the only section of the upper airway 
that showed a statistically significant change in the AP and cross-sectional area 
constrictions was the velopharynx and the change was positive. The oropharynx 
had a statistically significant change in the percentage change of the minimum 
cross-sectional area which was also positive. No parameter assessed in the 
upper airway showed a significant negative change. 
     In the pre-treatment airway, a majority of the patients (72%) had their most 
constricted AP and area in the velopharynx. This percentage correlates closely 
with studies showing successful treatment for OSA with an MRA at 76.2% [24]. In 
over half of these patients, the velopharynx is the only level of the upper airway 
that has a significant constriction (A-P length less than 6 mm and/or minimum 
cross-sectional area less than 90 mm2). 
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Conclusion 
1. MRA therapy typically increases the AP dimension and cross-sectional 
area of the velopharynx. In contrast, MRA therapy did not reliably 
increase oropharynx and hypopharynx dimensions. 
2. AP length and minimum cross-sectional area of constriction did not 
correlate with OSA category, suggesting that factors other than the 
anatomic constriction play a role in OSA development.  
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